EPIX (ESSA Pharma Inc.) Kacepetan wutah bathi saben saham ing taun lumaku

ESSA Pharma Inc. (EPIX) is developing high-precision therapies to block tumor receptors, focusing on N-terminal domain inhibition in cases of resistance to standard treatment. The year-over-year earnings per share dynamics on GURU.Markets capture the current trend, where 0.00 records a new level. The company's strategy relies on its own pipeline tests and targeted alliances with the largest pharma behemoths.

EPIX - Wutah bathi ing taun lumaku essapharma.com ing rentang 04.07.2022 - 25.10.2025

Rincian analitis lan laporan data perusahaan essapharma.com (EPIX)

- rega lan prakiraan konsensus rega:

Kutipan saham ESSA Pharma|EPIX - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar ESSA Pharma|EPIX - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham ESSA Pharma|EPIX - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku essapharma.com|EPIX - Aset Agregat Perusahaan

- rincian utang lan likuiditas:

Koefisien Total Utang marang Modal ESSA Pharma Inc.|EPIX - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal ESSA Pharma|EPIX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ESSA Pharma|EPIX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan ESSA Pharma|Rasio likuiditas kritis essapharma.com

- statistik bathi lan rasio pasar:

EPIX - Bathi resik|Penghasilan resik sing dikarepake ESSA Pharma Inc.|EPIX - Pangali P/E|Pangali Forward P/E ESSA Pharma|EPIX - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan ESSA Pharma|EPIX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan ESSA Pharma|EPIX - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan essapharma.com|EPIX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep ESSA Pharma Inc.

Pambiji fundamental:ESSA Pharma Inc.

Analyzing the annual earnings per share growth rate for the biotech issuer ESSA Pharma Inc. (EPIX), we assess the dynamics of net income per share. This metric measures the percentage change in EPS, neutralizing time gaps between quarterly reports. The current value of 0.00 reflects high capital sensitivity to operating expenses. For a company without commercial revenue, this indicator marks the cash burn rate prior to the publication of Phase 1/2 results. A negative or unstable curve confirms high pipeline risks.

Pesaing wigati

Wutah bathi resik saben saham ing taun iki Merus NV|IMMP (Immutep Limited ADR) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Anixa Bio ANIX|Wutah bathi saben saham ing taun lumaku Atossa Therapeutics (ATOS)|contexttherapeutics.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku MRSN (Mersana Therapeutics, Inc.)|BriaCell Therapeutics Corp. (BCTX) - Kacepetan wutah bathi saben saham ing taun lumaku|QTI - Wutah bathi saben saham ing taun lumaku